Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 2/20 | 0.37 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.37 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.37 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22051005 | 0.92 | SLC2A1 (0.40) | TSHRSLC2A1AKR1C3AKR1C2HSD17B2 | |
| SCHEMBL22060593 | 0.92 | RAPGEF4 (0.44) | TSHRSLC2A1AKR1C3AKR1C2HSD17B2 | |
| SCHEMBL23589544 | 0.89 | AKR1C3 (0.44) | TSHRSLC2A1AKR1C3AKR1C2HSD17B2 | |
| SCHEMBL29454091 | 0.89 | MAPT (0.39) | TSHRSLC2A1AKR1C3AKR1C2HSD17B2 | |
| SCHEMBL23589605 | 0.84 | SLC2A1 (0.42) | TSHRSLC2A1AKR1C3AKR1C2HSD17B2 | |
| SCHEMBL29292631 | 0.84 | SLC2A1 (0.36) | TSHRSLC2A1AKR1C3AKR1C2HSD17B2 | |
| SCHEMBL29292712 | 0.84 | FGFR2 (0.44) | SLC2A1AKR1C3AKR1C2NPC1RAB9A | |
| SCHEMBL30574528 | 0.84 | RAPGEF4 (0.40) | TSHRHSD17B2 | |
| SCHEMBL24178525 | 0.81 | RAB9A (0.42) | TSHRSLC2A1AKR1C3AKR1C2NPC1 | |
| SCHEMBL23908291 | 0.81 | RAPGEF4 (0.45) | RAB9ASMN1; SMN2ALDH1A1MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11845768-B2 | Polycyclic compound and organic light-emitting device including same | LG CHEM, LTD. (KR) | 2023-12-19 | — | — | US | disclosed |
| CN-112585145-B | Polycyclic compound and organic light emitting device including the same | 株式会社LG化学 | 2023-09-29 | — | — | CN | disclosed |
| US-20210317147-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | LG CHEM, LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
| US-20210317147-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | LG CHEM, LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317147-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CYP1A1, CRY1, CYP1B1 | TSHR 4541/4885SLC2A1 4640/4885AKR1C3 1070/4885 |
| US-11845768-B2 | Polycyclic compound and organic light-emitting device including same | CRY1, CYP1A1, CRY2 | TSHR 4473/4885SLC2A1 4421/4885AKR1C3 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.